News - Events

This meeting will bring experts on biosimilar medicines together with practitioners to discuss the development and commercialisation of biosimilars, which are off-patent versions of biologic drugs. The conference will discuss biosimilar manufacturing and commercialisation considerations specific to the US, featuring case studies of approved products. In March, the US Food and Drug Administration Commissioner Scott Gottlieb said that registering biosimilar medicines was a priority for the FDA.

This meeting will host 4,500 leaders in the global life science industry who are involved in the  discovery and development of new drugs, the financing of start-up companies and public policy. Among the keynote addresses will be a presentation about how pharma and venture capital combinations are changing the industry.  

Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Nullam quis risus eget urna mollis ornare vel eu leo. Donec ullamcorper nulla non metus auctor fringilla. Donec ullamcorper nulla non metus auctor fringilla. Etiam porta sem malesuada magna mollis euismod. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

Biosimilar medicines, which are follow-on products to biologics, have started to have an impact on pharmaceutical markets in Europe in the US.

This is the 10th annual Cell and Tissue Culture event and will feature presentations about the use of advanced cell cultures in research, including the study of neurological diseases and disorders

This meeting will discuss the role of molecular diagnostics in the rapid detection of serious diseases. These range from cancer to infectious diseases.

ADMET, or absorption, distribution, metabolism and excretion, describes how a pharmaceutical medicine in take into the body, exposed to tissues, metabolises and is finaly excreted.

Pharmaceutical microbiology describes the identification of microorganisms associated with pharmaceutical manufacture, and strategies for removing them in order to ensure that the final drug produc

Approaching its 12th consecutive year, BioTrinity is a network and partnering platform for the global life sciences industry with the goal of helping shape the future of healthcare.